Cargando…

Use of Anticoagulation Therapy in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-analysis

BACKGROUND: Perioperative atrial fibrillation (POAF) after cardiac surgery is associated with an increased risk of stroke. However, the efficacy and safety of using anticoagulation therapy in this population are unknown. METHODS: We performed a systematic review and meta-analysis of studies comparin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Michael Ke, Heo, Rachel, Meyre, Pascal, Park, Louis, Blum, Steffen, McIntyre, William F., Belley-Côté, Emilie, Birchenough, Lauren, Vuong, Kiven, Healey, Jeff S., Devereaux, P.J., Lamy, André, Conen, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568684/
https://www.ncbi.nlm.nih.gov/pubmed/36254332
http://dx.doi.org/10.1016/j.cjco.2022.06.003
_version_ 1784809690287308800
author Wang, Michael Ke
Heo, Rachel
Meyre, Pascal
Park, Louis
Blum, Steffen
McIntyre, William F.
Belley-Côté, Emilie
Birchenough, Lauren
Vuong, Kiven
Healey, Jeff S.
Devereaux, P.J.
Lamy, André
Conen, David
author_facet Wang, Michael Ke
Heo, Rachel
Meyre, Pascal
Park, Louis
Blum, Steffen
McIntyre, William F.
Belley-Côté, Emilie
Birchenough, Lauren
Vuong, Kiven
Healey, Jeff S.
Devereaux, P.J.
Lamy, André
Conen, David
author_sort Wang, Michael Ke
collection PubMed
description BACKGROUND: Perioperative atrial fibrillation (POAF) after cardiac surgery is associated with an increased risk of stroke. However, the efficacy and safety of using anticoagulation therapy in this population are unknown. METHODS: We performed a systematic review and meta-analysis of studies comparing use of anticoagulation therapy vs no anticoagulation therapy in patients with POAF after cardiac surgery. Outcomes included arterial thromboembolism (ie, stroke ± systemic embolism) and bleeding. Data were pooled using fixed-effects models. We reported summary risk ratios (RRs) for studies with multivariable adjustment and estimated absolute risk differences with 95% confidence intervals (CIs). RESULTS: Nine observational studies met eligibility criteria. No randomized trials were identified. Of the 254,200 POAF patients included, 27.3% received anticoagulation. Six studies reported outcomes after long-term follow-up (median 5.0 years; range 4.2-10.0). The risk of arterial thromboembolism was lower in patients receiving anticoagulation therapy (RR 0.83; 95% CI, 0.69-0.99; I(2) = 57%; P = 0.04; 6 studies). The estimated short-term and long-term absolute risk reductions in arterial thromboembolism with use of anticoagulation therapy were 0.8% (95% CI, 0.4-1.4) and 2 events per 1000 person-years (95% CI, 0-4), respectively. The risk of bleeding was higher in patients receiving anticoagulation therapy (RR 3.22; 95% CI, 2.82-3.68; I(2) = 98%; P < 0.001; 2 studies). The estimated short-term and long-term absolute risk increases in bleeding with use of anticoagulation therapy were 0.5% (95% CI, 0.4-0.6) and 42 events per 1000 person-years (95% CI, 35-51), respectively. CONCLUSIONS: Use of anticoagulation therapy is associated with a small reduction in the risk of arterial thromboembolism, but also an increased risk of bleeding. Randomized controlled trials are needed to address this issue.
format Online
Article
Text
id pubmed-9568684
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95686842022-10-16 Use of Anticoagulation Therapy in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-analysis Wang, Michael Ke Heo, Rachel Meyre, Pascal Park, Louis Blum, Steffen McIntyre, William F. Belley-Côté, Emilie Birchenough, Lauren Vuong, Kiven Healey, Jeff S. Devereaux, P.J. Lamy, André Conen, David CJC Open Systematic Review/Meta-Analysis BACKGROUND: Perioperative atrial fibrillation (POAF) after cardiac surgery is associated with an increased risk of stroke. However, the efficacy and safety of using anticoagulation therapy in this population are unknown. METHODS: We performed a systematic review and meta-analysis of studies comparing use of anticoagulation therapy vs no anticoagulation therapy in patients with POAF after cardiac surgery. Outcomes included arterial thromboembolism (ie, stroke ± systemic embolism) and bleeding. Data were pooled using fixed-effects models. We reported summary risk ratios (RRs) for studies with multivariable adjustment and estimated absolute risk differences with 95% confidence intervals (CIs). RESULTS: Nine observational studies met eligibility criteria. No randomized trials were identified. Of the 254,200 POAF patients included, 27.3% received anticoagulation. Six studies reported outcomes after long-term follow-up (median 5.0 years; range 4.2-10.0). The risk of arterial thromboembolism was lower in patients receiving anticoagulation therapy (RR 0.83; 95% CI, 0.69-0.99; I(2) = 57%; P = 0.04; 6 studies). The estimated short-term and long-term absolute risk reductions in arterial thromboembolism with use of anticoagulation therapy were 0.8% (95% CI, 0.4-1.4) and 2 events per 1000 person-years (95% CI, 0-4), respectively. The risk of bleeding was higher in patients receiving anticoagulation therapy (RR 3.22; 95% CI, 2.82-3.68; I(2) = 98%; P < 0.001; 2 studies). The estimated short-term and long-term absolute risk increases in bleeding with use of anticoagulation therapy were 0.5% (95% CI, 0.4-0.6) and 42 events per 1000 person-years (95% CI, 35-51), respectively. CONCLUSIONS: Use of anticoagulation therapy is associated with a small reduction in the risk of arterial thromboembolism, but also an increased risk of bleeding. Randomized controlled trials are needed to address this issue. Elsevier 2022-06-10 /pmc/articles/PMC9568684/ /pubmed/36254332 http://dx.doi.org/10.1016/j.cjco.2022.06.003 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review/Meta-Analysis
Wang, Michael Ke
Heo, Rachel
Meyre, Pascal
Park, Louis
Blum, Steffen
McIntyre, William F.
Belley-Côté, Emilie
Birchenough, Lauren
Vuong, Kiven
Healey, Jeff S.
Devereaux, P.J.
Lamy, André
Conen, David
Use of Anticoagulation Therapy in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-analysis
title Use of Anticoagulation Therapy in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-analysis
title_full Use of Anticoagulation Therapy in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-analysis
title_fullStr Use of Anticoagulation Therapy in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-analysis
title_full_unstemmed Use of Anticoagulation Therapy in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-analysis
title_short Use of Anticoagulation Therapy in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-analysis
title_sort use of anticoagulation therapy in patients with perioperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis
topic Systematic Review/Meta-Analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568684/
https://www.ncbi.nlm.nih.gov/pubmed/36254332
http://dx.doi.org/10.1016/j.cjco.2022.06.003
work_keys_str_mv AT wangmichaelke useofanticoagulationtherapyinpatientswithperioperativeatrialfibrillationaftercardiacsurgeryasystematicreviewandmetaanalysis
AT heorachel useofanticoagulationtherapyinpatientswithperioperativeatrialfibrillationaftercardiacsurgeryasystematicreviewandmetaanalysis
AT meyrepascal useofanticoagulationtherapyinpatientswithperioperativeatrialfibrillationaftercardiacsurgeryasystematicreviewandmetaanalysis
AT parklouis useofanticoagulationtherapyinpatientswithperioperativeatrialfibrillationaftercardiacsurgeryasystematicreviewandmetaanalysis
AT blumsteffen useofanticoagulationtherapyinpatientswithperioperativeatrialfibrillationaftercardiacsurgeryasystematicreviewandmetaanalysis
AT mcintyrewilliamf useofanticoagulationtherapyinpatientswithperioperativeatrialfibrillationaftercardiacsurgeryasystematicreviewandmetaanalysis
AT belleycoteemilie useofanticoagulationtherapyinpatientswithperioperativeatrialfibrillationaftercardiacsurgeryasystematicreviewandmetaanalysis
AT birchenoughlauren useofanticoagulationtherapyinpatientswithperioperativeatrialfibrillationaftercardiacsurgeryasystematicreviewandmetaanalysis
AT vuongkiven useofanticoagulationtherapyinpatientswithperioperativeatrialfibrillationaftercardiacsurgeryasystematicreviewandmetaanalysis
AT healeyjeffs useofanticoagulationtherapyinpatientswithperioperativeatrialfibrillationaftercardiacsurgeryasystematicreviewandmetaanalysis
AT devereauxpj useofanticoagulationtherapyinpatientswithperioperativeatrialfibrillationaftercardiacsurgeryasystematicreviewandmetaanalysis
AT lamyandre useofanticoagulationtherapyinpatientswithperioperativeatrialfibrillationaftercardiacsurgeryasystematicreviewandmetaanalysis
AT conendavid useofanticoagulationtherapyinpatientswithperioperativeatrialfibrillationaftercardiacsurgeryasystematicreviewandmetaanalysis